Abbott Laboratories & Joe Biden
2 shared events · Importance 3 · Last updated May 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Domestic
Abbott Laboratories: Abbott Laboratories, the maker of mifepristone, received temporary relief from Samuel Alito's order, allowing continued mail access to the drug. The company appealed to the United States — Supreme Court of the United States to set aside the appellate court's order and expressed concern about the 'immediate confusion and upheaval' caused by the 5th Circuit's decision.
Joe Biden: The Biden administration permanently eliminated the in-person mandate for mifepristone in December 2021, a decision that enabled abortion rights groups to make abortion pills accessible in every state despite Roe's end.
May 04, 2026 · 6 articles
Regulatory
Abbott Laboratories: Abbott Laboratories, a manufacturer of Mifepristone, is a defendant in the lawsuit and has requested a hold on the appeals court's order to seek relief from the United States — Supreme Court of the United States.
Joe Biden: Rules finalized under President Joe Biden that ended the in-person requirement for mifepristone were reversed by the appellate court, putting his administration's policy on abortion access under scrutiny.
May 01, 2026 · 78 articles
NEWSDESK
Explore this relationship live
Track how Abbott Laboratories and Joe Biden interact across events, view sentiment trends, and discover connected entities.
Open Dashboard